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1. Introduction 
The amebocytes of horseshoe crab (Limulus) hemo- 
lymph contain a coagulation system highly sensitive 
to bacterial endotoxins (lipopolysaccharides) [ 1,2]. 
This system seems to participate not only in haemo- 
stasis but also in defence against invading microorgan- 
isms [3]. In the amebocyte lysate, endotoxin has 
been reported to mediate directly the activation of a 
proclotting enzyme resulting in the transformation of 
coagulation to coagulin gel [4]. However, our recent 
studies have indicated that both amebocyte lysates 
from Limulus polyphemus and Tachypleus tridenta- 
tus contain at least two components beside coagu- 
logen, all of which are associated with the coagulation 
system [5 1. One of them is a new component sensi- 
tive to endotoxin, tentatively named factor B, and 
the other is a component corresponding to the known 
proclotting enzyme but insensitive to endotoxin. Dur- 
ing these studies, we were informed that, in addition 
to endotoxin, a water-soluble antitumor carboxy- 
methylated (1 + 3)Q-D-glucan (CMPS) activated the 
Limulus coagulation system and induced the clot for- 
mation [ 161. This result prompted us to examine 
which component associated with the coagulation 
system is activated by CMPS. We report here that 
neither factor B nor proclotting enzyme previously 
identified is sensitive to CMPS but that there exists a 
third component (tentatively named factor G) sensi- 
tive to CMPS, which mediates the activation of the 
proclotting enzyme to its active form. The results also 
suggest hat the Limulus amebocytes contain two 
independent coagulation pathways, endotoxin-medi- 
ated and (1 + 3)O-D-glucan-mediated pathways, both 
of which result in the transformation of coagulogen 
to coagulin. The latter pathway seems to correspond 
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to an alternative pathway found in the mammalian 
complement system. 
2. Materials and methods 
The amebocyte lysate from Tachypleus tridentatus 
(Japanese horseshoe crab) was prepared according to 
the method in [7]. A pyrogen-free carboxymethyl- 
ated (1 -+ 3)-/I-D-glucan (CMPS) used here was kindly 
supplied by Dr A. Kakinuma, Central Research Divi- 
sion, Takeda Chemical Industries (Osaka). Boc-Leu- 
Gly-Arg-p-nitroanilide (pNA) used as substrate for 
the Limulus clotting enzyme assay was a product of 
the Protein Research Foundation (Minoh, Osaka) and 
the amidase activity was measured by the method in 
[ 8,9]. Factor B used for the assay of preclotting 
enzyme was a preparation obtained in [S]. Endotoxin 
prepared from E. coli 011 l-B4 was a product of Sigma 
Chemical Co. (St Louis MO). Heparin-Sepharose 
CL6B was prepared as in [lo]. All glassware and 
buffer solutions were sterilized by heating at 200°C 
for 2 h and autoclaving at 120°C for 1.5 h, respectively. 
3. Results and discussion 
Fig.1 shows chromatographic separation of the 
lysate on a heparin-Sepharose CLdB column. When 
each fraction was incubated with factor B and Boc- 
Leu-Gly-Arg-pNA in the presence of endotoxin, a 
strong amidase activity appeared in both fractions A 
(proclotting enzyme fraction [5]) and G, and the lat- 
ter fraction contained coagulogen, which was detected 
by treating it with TPCK-trypsin. However, factor B 
sensitive to endotoxin [5] was eluted in fraction B in 
ElsevierjNorth-Holland Biomedical Press 
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an inactive form and its activity was easily detected 
after incubation with fraction A and Boc-Leu-Gly- 
Arg-pNA in the presence of endotoxin. 
The fractions A, G and B indicated by solid bars in 
fig.1 were collected and their amidase activities and 
clot-forming abilities were measured after treatments 
of the pooled fractions with CMPS instead of endo- 
toxin. As shown in exp. l-3 of table 1, these activi- 
ties were found only in fraction G, indicating that the 
fraction contains a CMPS-sensitive factor (tentatively 
named factor G). This fraction G also developed the 
amidase activity in the presence of a native (1 + 3) 
P-D-glucan (not shown). These results indicate that 
factor G found in fraction G is a new component sen- 
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Fig.1. Heparin-Sepharose CLdB column chromatography of Tachypleus tridentutus amebocyte lysate. The lysate (50 ml) pre- 
paredas in [7] was diluted 3-fold,using 0.05 M Tris-HCl buffer (pH 7.2) and applied to a column (5.0 X 1.7 cm), preequilibrated 
with the same buffer. The stepwise elution was performed at 4°C firstly with the equilibration buffer, secondly with the buffer 
containing 0.15 M NaCl, and finally with the buffer containing 0.45 M NaCl. Fractions of 15 ml were collected at a flow rate of 
73 ml/h, and the fractions A, G and B indicated by solid bars were collected. The amidase activity of the proclotting enzyme (0) 
was measured by activating it to the clotting enzyme in the presence of factor B and endotoxin. The reaction mixture contained 
50 ~1 of each fraction, 50 ~1 factor B (A180 = O.OSS), 0.4 mM Boc-Leu-Gly-Arg-pNA, endotoxin (final, 80 ng/ml), 80 mM 
Tris-HCl buffer (pH 8.0) and 5.2 mM MgCl,, in a total volume of 250 ~1. After incubation at 37’C for 20 min, 0.8 ml 0.6 M ace- 
tic acid was added to terminate the reaction and the absorbance at 405 nm was measured. Factor B activity (0) was detected by 
incubating each fraction with fraction A in the presence of endotoxin and the chromogenic substrate. The reaction mixture was 
the same as that above, except that 50 ~1 of fraction A instead of factor B was added. Coagulogen (o) was detected by testing the 
clot formation induced by trypsin; the mixture containing 500 ~1 fractions, 20 ).d TPCK-trypsin (1 mg/ml) and 100 ~10.2 M Tris- 
HCl/20 mM CaCI, buffer (pH 8.0) was incubated at 37°C for 15 min, and then 1.0 ml saline was added. The turbidity was mea- 
sured spectrophotometrically at 360 nm. Transmittance at 280 nm (..a.). 
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Table 1 
Recombination experiments of fractions A, G and B in the 
presence of carboxymethylated (1 -f 3)-P-D-glucan (CMPS) 
Table 2 
Recombination experiments of fractions A, G and B in the 
presence of E. coli 0 11 l-B4 endotoxin 
Exp. Fraction Amidase activity Clot-form- Exp. Fraction Amidase activity Clot-form- 
(X lo-‘) (pm01 ing ability (X lo-‘) (pm01 ing ability 
pNA released/ml) pNA released/ml) 
1 Fraction A 0 _ 
2 Fraction G 284 f 
3 Fraction B 0 _ 
1 Fraction A 0 _ 
2 Fraction G 0 _ 
3 Fraction B 51 _ 
4 Fractions A + G 455 + 
5 Fractions A + B 0 _ 
6 .Fractions G + B 313 + 
4 Fractions A + G 0 _ 
5 Fractions A + B 326 + 
6 Fractions G + B 414 + 
I Fractions A + G + B 491 + 
The reaction mixture containing 50 /.d each of fraction, 
CMPS (final, 24 ng/ml), 0.4 mM chromogenic substrate, 
80 mM Tris-HCl buffer (pH 8.0) and 5.2 mM MgCl,, in a 
total volume of 250 ~1, was incubated at 37°C for 30 min. 
Then, 0.8 ml 0.6 M acetic acid was added to terminate the 
reaction and the absorbance at 405 nm was measured [9]. In 
recombination experiments, 50 ~1 each of fractions A, G or B 
was mixed for each other and the amidase activity was mea- 
sured under the same conditions as above. A clot-forming 
ability of each fraction was tested by using a highly purified 
coagulogen [121 as follows. The reaction mixture contained 
50 ~1 each of fractions A, G and B or their combined mix- 
ture, 30 ~1 CMPS (400 ng/ml), 100 ~1 Tuchypleus coagulogen 
(2 mg/ml) and 50 /.d 0.4 M Tris-HCI buffer (pH 8.0) contain- 
ing 26 mM MgCl,, in a total volume of 330 ~1. When a clot 
appeared within 1 h at 37”C, it was judged that the sample 
showed a positive reaction 
I Fractions A + G + B 662 + 
The reaction conditions in these experiments were those of 
table 1, except that endotoxin (final, 24 ng/ml) instead of 
CMPS was used 
sibility that factor G activates a hitherto unknown 
proclotting enzyme eluted in fraction G, since the 
fraction itself treated with CMPS showed a strong 
amidase activity in the absence of fraction A (exp. 2). 
It is also possible to presume that active factor G 
itself may have a clot-forming activity. 
sitive to CMPS, and that it differs from coagulogen, 
proclotting enzyme and factor B all associated with 
the Limulus coagulation system. 
To elucidate further the relationship among the 
components in fractions A, G and B, a recombination 
experiment was performed, using CMPS as a mediator 
for the coagulation reaction. The results are also 
shown in table 1. A mixture of fraction G with frac- 
tion A (exp. 4) or fraction B (exp. 6) in the presence 
of CMPS showed a stronger amidase activity, as com- 
pared with fraction G alone. However, there was 
neither amidase activity nor clot-forming ability in 
the combination of fractions A and B (exp. 5). The 
maximum amidase activity was obtained in the mix- 
ture of fractions A, G and B (exp. 7). These results 
suggest again that a CMPS-sensitive factor, factor G, 
must be contained in fraction G and that the factor 
induces the activation of the known proclotting 
enzyme eluted in fraction A. However, there is a pos- 
Table 2 shows the recombination experiments in 
the presence of endotoxin. There was little or no ami- 
dase activity and clot-forming ability in fractions A, 
G and B alone (exp. l-3). However, on incubation of 
the reaction mixture of fractions A and B, a strong 
amidase activity, in addition to the clot-forming abil- 
ity, appeared, as shown in exp. 5 (table 2), and the 
result was the same as that in [5]. Moreover, the 
combined mixture of fractions G and B showed a 
stronger amidase activity and formed a clot (exp. 6). 
Ekdotoxin 
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Pro-clotting enzyme Clotting enzyme 
Coagulogen Coagultn 
Fig.2. Tentative mechanism for the coagulation cascade 
found in Lirnulus amebocyte lysate. Doubtless, this cascade 
sequence will need modification as new factors and cofactors 
are discovered, and further studies will be required for the 
identification of each component. 
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On the contrary, the combined mixture of frac- 
tions A and G did not show any activities, indicating 
that both were insensitive to endotoxin (exp. 4). The 
maximum amidase activity was obtained in the 
recombination of fractions A, G and B (exp. 7). 
These results indicate that factor G differs completely 
from factor B in its inability to respond to endotoxin. 
Based on the results described above, we would 
suggest new (1 + 3)$3-D-glucan-mediated coagulation 
pathway in Limulus amebocytes, as shown in fig.2. 
Thus, CMPS activates factor G and the active factor G 
converts the known proclotting enzyme to the clot- 
ting enzyme, which then catalyzes the transformation 
of coagulogen to coagulin gel. To establish the glucan- 
mediated pathway, in addition to the endotoxin- 
mediated pathway postulated in [ 5 ,111, detailed bio- 
chemical studies on the isolation and characterization 
of each component will be required. 
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